The Endocrine Society has been encouraged by the significant increases in funding for the National Institutes of Health (NIH) in fiscal years (FY) 2016 and 2017. However, further steady and sustainable increases in funding are needed to undo damage cause by years of flat funding prior to 2016. At the time this article was written,...
On July 7, Health and Human Services Secretary Tom Price announced that Brenda Fitzgerald had been selected as director of the Centers for Disease Control and Prevention (CDC). Fitzgerald is an obstetrician-gynecologist who served as the commissioner of the Georgia Department of Public Health. In that capacity, Fitzgerald served on an advisory council on childhood...
The U.S. Senate was working hard to develop its version of a health reform measure, but timetable expectations continue to shift. The U.S. House of Representatives passed its version of a health reform bill in May; the Senate leadership had hoped to pass an alternative healthcare coverage measure by the end of June. Senate Republicans...
During the past three years, the Endocrine Society has worked to expand its global advocacy concerning endocrine-disrupting chemicals (EDCs). The Society has become a recognized leader in advocating for policies and regulatory strategies for EDCs that reflect the latest endocrine science and incorporate principles of endocrinology. EDCs are chemicals that interfere with the normal function...
As reported previously in the May issue of Endocrine News, the National Institutes of Health (NIH) proposed to implement a new policy to place a cap on total research support that may be received by an individual investigator. The cap, based on a metric called the Grant Support Index (GSI), would be equivalent to 3...
When the U.S. House of Representatives passed health reform legislation in yet another attempt to repeal Obamacare, there were more questions than answers. Endocrine News examines the new bill to let you know what’s in it, what’s not, what’s at stake, where the Endocrine Society stands, and what’s next for you and your patients. On...
The Endocrine Society warned that the president’s proposal to slash $7.16 billion, or more than a fifth, of the National Institutes of Health’s (NIH’s) budget, and $1.2 billion from the Centers for Disease Control and Prevention (CDC) would hinder progress toward needed medical treatments and advances in public health and disease prevention. President Trump released...
By April 27, both the U.S. House of Representatives and the Senate passed legislation to keep the government funded through September 30, 2017 and it included a $2 billion increase for the National Institutes of Health (NIH). This was one of the Endocrine Society’s top advocacy priorities as grant funding for our member researchers was...
On July 7, Health and Human Services Secretary Tom Price announced that Brenda Fitzgerald had been selected as director of the Centers for Disease Control and Prevention (CDC). Fitzgerald is an obstetrician-gynecologist who served as the commissioner of the Georgia Department of Public Health. In that capacity, Fitzgerald served on an advisory council on childhood...
When the U.S. House of Representatives passed health reform legislation in yet another attempt to repeal Obamacare, there were more questions than answers. Endocrine News examines the new bill to let you know what’s in it, what’s not, what’s at stake, where the Endocrine Society stands, and what’s next for you and your patients. On...
